Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells
- PMID: 22873792
- PMCID: PMC3487741
- DOI: 10.1186/1748-717X-7-135
Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells
Abstract
Background: Oral cancer is a common cancer and a major health problem in the Indian subcontinent. At our laboratory Mcl-1, an anti-apoptotic member of the Bcl-2 family has been demonstrated to be overexpressed in oral cancers and to predict outcome in oral cancer patients treated with definitive radiotherapy. To study the role of Mcl-1 isoforms in radiation response of oral squamous carcinoma cells (OSCC), we investigated in the present study, the association of Mcl-1 isoform expression with radiosensitivity of OSCC, using siRNA strategy.
Methods: The time course expression of Mcl-1 splice variants (Mcl-1L, Mcl-1S & Mcl-1ES) was studied by RT-PCR, western blotting & immunofluorescence, post-irradiation in oral cell lines [immortalized FBM (radiosensitive) and tongue cancer AW8507 & AW13516 (radioresistant)]of relatively differing radiosensitivities. The effect of Mcl-1L knockdown alone or in combination with ionizing radiation (IR) on cell proliferation, apoptosis & clonogenic survival, was investigated in AW8507 & AW13516 cells. Further the expression of Mcl-1L protein was assessed in radioresistant sublines generated by fractionated ionizing radiation (FIR).
Results: Three to six fold higher expression of anti-apoptotic Mcl-1L versus pro-apoptotic Mcl-1S was observed at mRNA & protein levels in all cell lines, post-irradiation. Sustained high levels of Mcl-1L, downregulation of pro-apoptotic Bax & Bak and a significant (P < 0.05) reduction in apoptosis was observed in the more radioresistant AW8507, AW13516 versus FBM cells, post-IR. The ratios of anti to pro-apoptotic proteins were high in AW8507 as compared to FBM. Treatment with Mcl-1L siRNA alone or in combination with IR significantly (P < 0.01) increased apoptosis viz. 17.3% (IR), 25.3% (siRNA) and 46.3% (IR plus siRNA) and upregulated pro-apoptotic Bax levels in AW8507 cells. Combination of siRNA & IR treatment significantly (P < 0.05) reduced cell proliferation and clonogenic survival of radioresistant AW8507 & AW13516 cells, suggesting a synergistic effect of the Mcl-1L siRNA with IR on radiosensitivity. Interestingly, during the development of radioresistant sublines using FIR, high expression of Mcl-1L was observed.
Conclusion: Our studies suggest that Mcl-1L isoform has an important role in the survival and radioresistance of OSCC and may be a promising therapeutic target in oral cancers.
Figures








Similar articles
-
Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers.PLoS One. 2014 Nov 19;9(11):e111927. doi: 10.1371/journal.pone.0111927. eCollection 2014. PLoS One. 2014. PMID: 25409302 Free PMC article.
-
Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1.J Pathol. 2009 Feb;217(3):398-407. doi: 10.1002/path.2459. J Pathol. 2009. PMID: 19009587
-
MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis.PLoS One. 2013 Nov 18;8(11):e79626. doi: 10.1371/journal.pone.0079626. eCollection 2013. PLoS One. 2013. PMID: 24260268 Free PMC article.
-
Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer.Cell Death Dis. 2024 Dec 18;15(12):917. doi: 10.1038/s41419-024-07307-z. Cell Death Dis. 2024. PMID: 39695189 Free PMC article. Review.
-
Bcl-2 family proteins in breast development and cancer: could Mcl-1 targeting overcome therapeutic resistance?Oncotarget. 2015 Feb 28;6(6):3519-30. doi: 10.18632/oncotarget.2792. Oncotarget. 2015. PMID: 25784482 Free PMC article. Review.
Cited by
-
Function, clinical application, and strategies of Pre-mRNA splicing in cancer.Cell Death Differ. 2019 Jul;26(7):1181-1194. doi: 10.1038/s41418-018-0231-3. Epub 2018 Nov 21. Cell Death Differ. 2019. PMID: 30464224 Free PMC article. Review.
-
Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells.Comput Struct Biotechnol J. 2019 Jan 26;17:151-159. doi: 10.1016/j.csbj.2019.01.004. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 30788081 Free PMC article.
-
Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events.RNA. 2014 Oct;20(10):1621-31. doi: 10.1261/rna.045583.114. Epub 2014 Aug 19. RNA. 2014. PMID: 25140042 Free PMC article.
-
Overexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancers.PLoS One. 2014 Nov 19;9(11):e111927. doi: 10.1371/journal.pone.0111927. eCollection 2014. PLoS One. 2014. PMID: 25409302 Free PMC article.
-
BH3 mimetic Obatoclax (GX15-070) mediates mitochondrial stress predominantly via MCL-1 inhibition and induces autophagy-dependent necroptosis in human oral cancer cells.Oncotarget. 2016 Aug 5;8(36):60060-60079. doi: 10.18632/oncotarget.11085. eCollection 2017 Sep 1. Oncotarget. 2016. PMID: 28947954 Free PMC article.
References
-
- Mathew Iype E, Pandey M, Mathew A, Thomas G, Krishnan Nair M. Squamous cell cancer of the buccal mucosa in young adults. Br J Oral Maxillofac Surg. 2004;42:185–189. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials